A comparison of the outcomes of children with acute myelogenous leukemia in either first or second complete remission (CR1 vs CR2) following allogeneic hematopoietic stem cell transplantation at a single transplant center-Reference-Cited by-同舟云学术

A comparison of the outcomes of children with acute myelogenous leukemia in either first or second complete remission (CR1 vs CR2) following allogeneic hematopoietic stem cell transplantation at a single transplant center

Published:2008-02-11 Issue:11 Volume:41 Page:941-945
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Gassas A,Ishaqi M Kashif,Afzal S,Finkelstein-Shechter T,Dupuis A,Doyle J

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt200816.pdf

Reference20 articles.

1. Arceci RJ . Progress and controversies in the treatment of pediatric acute myelogenous leukemia. Curr Opin Hematol 2002; 9: 353–360.

2. Gibson BE, Wheatley K, Hann IM, Stevens RF, Webb D, Hills RK et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005; 19: 2130–2138.

3. Ravindranath Y, Chang M, Steuber CP, Becton D, Dahl G, Civin C et al. Pediatric Oncology Group. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005; 19: 2101–2116.

4. Webb DK, Wheatley K, Harrison G, Stevens RF, Hann IM . Outcome for children with relapsed acute myeloid leukemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukemia Working Party. Leukemia 1999; 13: 25–31.

5. Runts JE, Razzouk BI, Lensing S, Pounds S, Pui CH, Ribeiro RC . Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia. Cancer 2007; 109: 157–163.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children’s Oncology Group experience;Bone Marrow Transplantation;2022-01-06

2. Bone marrow transplant for the patient with primary immune deficiency disorder;Allergic and Immunologic Diseases;2022

4. Hematopoietic stem cell transplantation in pediatric patients with acute myeloid leukemia without favorable cytogenetics;Pediatric Transplantation;2017-08-01

5. Hematopoietic Cell Transplantation for Childhood Acute Myeloid Leukemia;Thomas’ Hematopoietic Cell Transplantation;2016-01-01